Internal Medicine, Hematology & Oncology · Brooksville, FL
NPI
1861735888
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
15211 Cortez Blvd
Brooksville, FL, 34613
Phone (352) 345-4565
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
221,085 services
Medicare patients, 2024
418
Average age 75
Drug cost, 2024
$6.6M
2,450 prescriptions
Company payments, 2025
$13K
From 55 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aaron C Denson was code J1437 (injection, ferric derisomaltose, 10 mg), 10,800 times for 83 patients. In total Aaron C Denson billed 221,085 services in 161 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 10,800 | 83 | $15.62 | $169K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 10,710 | 11 | $0.26 | $2,831 |
| J0897 Injection, denosumab, 1 mg | Office | 10,021 | 41 | $20.47 | $205K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 8,260 | 26 | $6.38 | $53K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,650 | 13 | $0.11 | $864 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 6,020 | 19 | $5.83 | $35K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,617 | 22 | $0.10 | $268 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,406 | 46 | $0.09 | $217 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 2,140 | 31 | $0.26 | $559 |
| 85025 Blood Count | Office | 1,440 | 356 | $7.59 | $11K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,214 | 14 | $3.56 | $4,320 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,080 | 24 | $0.75 | $811 |
| 36415 Venipuncture Blood Collection | Office | 990 | 338 | $8.65 | $8,564 |
| 96372 Injection Administration | Office | 802 | 127 | $10.35 | $8,302 |
| 96367 Intravenous Infusion, Hydration | Office | 684 | 62 | $20.80 | $14K |
By year: 2022 $4.2M for 432,189 services; 2023 $3.2M for 302,310 services; 2024 $3.2M for 221,085 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,440 | 356 | $7.59 | $11K |
| 36415 Venipuncture Blood Collection | 990 | 338 | $8.65 | $8,564 |
| 80053 Clinical Chemistry | 565 | 246 | $10.35 | $5,848 |
| 82728 Clinical Chemistry | 311 | 190 | $13.36 | $4,155 |
| 82747 Clinical Chemistry | 126 | 101 | $17.30 | $2,180 |
| 86300 Immunoassay | 67 | 40 | $20.39 | $1,366 |
| 84153 Clinical Chemistry | 37 | 21 | $18.02 | $667 |
| 82378 Clinical Chemistry | 35 | 20 | $18.58 | $650 |
Medicare prescription drug claims, 2024
In 2024, the drug Aaron C Denson prescribed most often to Medicare patients was Anastrozole, with 269 prescriptions and refills. In total Aaron C Denson wrote 2,450 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 269 | 718 | 91 | $6,861 |
| Oxycodone Hcl Generic | 261 | 261 | 78 | $9,453 |
| Ondansetron Odt Ondansetron | 183 | 183 | 94 | $9,330 |
| Letrozole Generic | 102 | 237 | 27 | $2,509 |
| Prednisone Generic | 92 | 109 | 28 | $592 |
| Abiraterone Acetate Generic | 90 | 90 | 13 | $245K |
| Eliquis Apixaban | 67 | 87 | 17 | $49K |
| Acyclovir Generic | 61 | 73 | 12 | $1,502 |
| Xtandi Enzalutamide | 60 | 60 | Under 11 | $842K |
| Morphine Sulfate Er Morphine Sulfate | 59 | 59 | 26 | $1,657 |
| Hydroxyurea Generic | 49 | 131 | 15 | $1,160 |
| Prochlorperazine Maleate Generic | 49 | 49 | 29 | $895 |
| Ondansetron Hcl Generic | 45 | 45 | 18 | $3,885 |
| Calquence Acalabrutinib Maleate | 43 | 43 | Under 11 | $649K |
| Imatinib Mesylate Generic | 40 | 40 | Under 11 | $90K |
Brand drugs: 563 claims; generic drugs: 1,887 claims; opioid claims: 370.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aaron C Denson $13K ($13K in general payments such as food, travel and fees) from 55 companies. The largest payer was Kyowa Kirin, Inc. with $3,418.
| Company | Payments | Amount |
|---|---|---|
| Kyowa Kirin, Inc. 4151.T | 2 | $3,418 |
| Novartis Pharmaceuticals Corporation NVS | 33 | $1,310 |
| GlaxoSmithKline, LLC. GSK | 17 | $1,225 |
| E.R. Squibb & Sons, L.L.C. BMY | 21 | $1,002 |
| Celgene Corporation BMY | 28 | $628 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $370 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $340 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $300 |
| Gilead Sciences, Inc. GILD | 13 | $267 |
| Incyte Corporation INCY | 12 | $237 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.